Patents Assigned to Mabloc, Inc.
  • Patent number: 11479598
    Abstract: Antibodies and antigen-binding fragments thereof specific to the YFV E protein and with neutralizing potency against YFV are provided. These antibodies and antigen-binding fragments are useful in treating YFV.
    Type: Grant
    Filed: November 24, 2020
    Date of Patent: October 25, 2022
    Assignee: Mabloc, Inc.
    Inventors: Anna Wec, Laura Walker